These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The use of CT in dementia. Pasi M; Poggesi A; Pantoni L Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S6-12. PubMed ID: 21729420 [TBL] [Abstract][Full Text] [Related]
49. What can imaging tell us about cognitive impairment and dementia? Narayanan L; Murray AD World J Radiol; 2016 Mar; 8(3):240-54. PubMed ID: 27029053 [TBL] [Abstract][Full Text] [Related]
50. Distinct influence of specific versus global connectivity on the different Alzheimer's disease biomarkers. Mutlu J; Landeau B; Gaubert M; de La Sayette V; Desgranges B; Chételat G Brain; 2017 Dec; 140(12):3317-3328. PubMed ID: 29194503 [TBL] [Abstract][Full Text] [Related]
51. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus. Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942 [TBL] [Abstract][Full Text] [Related]
52. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]
54. Neuroimaging in human immunodeficiency virus infection. Tucker KA; Robertson KR; Lin W; Smith JK; An H; Chen Y; Aylward SR; Hall CD J Neuroimmunol; 2004 Dec; 157(1-2):153-62. PubMed ID: 15579293 [TBL] [Abstract][Full Text] [Related]
55. [Biomarkers for dementia and other neurodegenerative diseases : Current developments]. Wiltfang J; Lewczuk P; Otto M Nervenarzt; 2016 Dec; 87(12):1305-1309. PubMed ID: 27844089 [TBL] [Abstract][Full Text] [Related]
56. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. Nasrallah IM; Wolk DA J Nucl Med; 2014 Dec; 55(12):2003-11. PubMed ID: 25413136 [TBL] [Abstract][Full Text] [Related]
57. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies. Devous MD Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405 [TBL] [Abstract][Full Text] [Related]
58. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. Silverman DH J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255 [TBL] [Abstract][Full Text] [Related]
59. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β. Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000 [TBL] [Abstract][Full Text] [Related]
60. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan]. Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]